FNCH
Finch Therapeutics Group, Inc.
Key Financials
Operating Income
$-83861000
↑ 27.5%
Net Income
$-74754000
↑ 34.8%
Total Assets
$55.4M
↓ 66.0%
Revenue
$107000
↓ 87.6%
Shareholders' Equity
$22.9M
↓ 76.1%
EPS (Diluted)
$-46.59
↓ 1841.3%
Total Liabilities
$32.5M
↓ 51.7%
Cash & Equivalents
$25.1M
↓ 64.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FNCH |
| Company Name | Finch Therapeutics Group, Inc. |
| CIK | 1733257 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-229-6499 |